Skip to main content
DNA Labs India

RYR1 Gene Central Core Disease NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

RYR1 Gene Central Core Disease NGS Genetic Test

Short Name: RYR1 CCD NGS Test

Also known as: RYR1 Gene Mutation Test, Central Core Disease Genetic Test, RYR1 NGS Panel, CCD NGS Genetic Test

RYR1 Gene Central Core Disease NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One Drop Blood on FTA Card samples. Results in Reports are available within 3 to 4 weeks after the sample reaches the lab.. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the RYR1 Gene Central Core Disease NGS Genetic Test is to confirm a clinical diagnosis of Central Core Disease by detecting pathogenic variants in the RYR1 gene. It also helps differentiate CCD from other congenital myopathies, guide management strategies, assess recurrence risks for families, and aid in carrier testing when relevant.

Test Code
3944
Price
₹20,000
Sample Type
Blood or Extracted DNA or One Drop Blood on FTA Card
Result Time
Reports are available within 3 to 4 weeks after the sample reaches the lab.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation is required. A genetic counseling session is recommended prior to testing.

Method: Peripheral blood draw or dried blood spot on FTA card

Step 2

Laboratory Analysis

A small blood sample will be collected by a trained phlebotomist, or a few drops will be placed on an FTA card.

Step 3

Report Delivery

No restrictions. You can resume normal activities immediately.

Timeline: Reports are available within 3 to 4 weeks after the sample reaches the lab.

Patient Instructions

1
Before the Test:Ready to know your genetic status? No prior fasting or preparation is required. A genetic counseling session is recommended to understand the purpose and risks.
2
During the Test:Our trained phlebotomist will collect a small blood sample (or FTA card drops). The process takes less than 10 minutes.
3
After the Test:You may receive post-test genetic counselling. Reports will be shared after 3-4 weeks.

About This Test

Who Should Get This Test

The purpose of the RYR1 Gene Central Core Disease NGS Genetic Test is to confirm a clinical diagnosis of Central Core Disease by detecting pathogenic variants in the RYR1 gene. It also helps differentiate CCD from other congenital myopathies, guide management strategies, assess recurrence risks for families, and aid in carrier testing when relevant.

How to Prepare

  • No fasting is required.
  • Ensure the sample is collected in an EDTA tube if blood is drawn.
  • If using an FTA card, allow the blood spot to air dry before packaging.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Early genetic testing for Central Core Disease enables timely family counselling and proactive management of symptoms."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One Drop Blood on FTA Card
Collection MethodPeripheral blood draw or dried blood spot on FTA card

Sample Stability

Blood samples should be transported to the laboratory as soon as possible.
FTA card samples are stable at room temperature for several weeks.
Sample Rejection Criteria:
  • Hemolysed or clotted blood sample
  • Insufficient sample quantity
  • Improperly labeled specimen
  • Sample leaking during transport

Understanding Your Results

The result should be interpreted in the context of clinical findings and family history. A positive result indicates a pathogenic RYR1 variant.
📊

Pathogenic variant(s) detected

Confirms the diagnosis of Central Core Disease in a symptomatic individual.

📊

No pathogenic variant detected

Reduces the likelihood of RYR1-related CCD, but cannot completely rule it out.

📊

Variant of uncertain significance (VUS)

Additional family testing or functional studies may be needed.

⚠️ When to Consult a Doctor:

If you experience unexplained muscle weakness, delayed motor development, or have a family history of Central Core Disease, consult a neurologist or genetic counselor.

Limitations

  • NGS may not detect deep intronic mutations, large structural variants, or trinucleotide repeat expansions.
  • Results may include variants of uncertain clinical significance (VUS).
  • A negative result does not fully exclude CCD if clinical suspicion remains strong.

Risks & Considerations

  • No significant risks. Minor bruising may occur at the puncture site.

Interfering Factors

  • Sample contamination or degradation
  • Incomplete clinical information or family history
  • Incorrect sample collection or labeling

Frequently Asked Questions

What is the RYR1 Gene Central Core Disease NGS Genetic Test?
It is a next-generation sequencing test that analyzes the RYR1 gene for pathogenic mutations associated with Central Core Disease, a rare inherited muscle disorder.
Why is this test recommended?
It is recommended to confirm a clinical diagnosis of Central Core Disease, identify carriers, and guide family planning and management decisions.
How much does the test cost?
The test costs INR 20,000 at DNA Labs India, which includes free home sample collection and a comprehensive clinical report.
What sample is required?
The test requires a blood sample, extracted DNA, or a single drop of blood on an FTA card.
Do I need to fast before the test?
No, fasting is not required for this genetic test.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after the sample reaches the laboratory.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for online bookings across multiple cities in India.
Will I receive raw data along with the report?
Yes, DNA Labs India uniquely provides raw data, FASTQ, and VCF files along with the conclusive clinical report for full transparency.
Can this test detect mutations in carriers?
Yes, the test can identify pathogenic or likely pathogenic variants in the RYR1 gene, which may have reproductive implications for family members.
What is NGS technology?
Next-generation sequencing (NGS) is a high-throughput sequencing method that allows rapid analysis of multiple genes or gene regions simultaneously, providing accurate and comprehensive mutation detection.
Is the test covered by insurance?
Coverage depends on the insurance provider. You may need to check with your specific plan. Government schemes do not routinely cover this DNA test.
How can I book the test?
You can book the test online through DNA Labs India's website or contact their customer care for assistance.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.